TY - JOUR
T1 - A case of metachronous liver metastasis of gallbladder cancer successfully treated by hepatectomy after chemotherapy
AU - Asano, Yukio
AU - Arakawa, Satoshi
AU - Ito, Masahiro
AU - Kato, Hiroyuki
AU - Shimura, Masahiro
AU - Hayashi, Chihiro
AU - Ochi, Takayuki
AU - Kamio, Kenshiro
AU - Kawai, Toki
AU - Yasuoka, Hironobu
AU - Higashiguchi, Takahiko
AU - Horiguchi, Akihiko
N1 - Publisher Copyright:
© 2020 Japanese Journal of Cancer and Chemotherapy Publishers Inc.. All rights reserved.
PY - 2020/10
Y1 - 2020/10
N2 - We present the case of a 66-year-old female diagnosed with gallbladder cancer that was initially discovered with contrast enhanced computed tomography. The primary gall bladder tumor displayed heterogeneous enhancement. The patient underwent cholecystectomy with full-thickness excision of the gallbladder cancer. After 3 rounds of adjuvant chemotherapy with the oral fluoropyrimidine derivative, S-1 (administered for 4 weeks at 120 mg/day and then stopped for 2 weeks), a metastasis measuring 15 mm in diameter emerged within hepatic segment 5. The chemotherapy regimen was altered to include 6 months of combination therapy with gemcitabine (1,000 mg/m') and cisplatin (25 mg/m2) given once every week for 2 weeks and then stopped for 1 week. The hepatic metastasis decreased in size to 8 mm in diameter, and a partial liver resection was performed. After hepatectomy, the patient remains alive and without disease recurrence. Key words: Liver metastasis of gallbladder cancer, Chemotherapy, Metachronous liver metastasis (Received Mar. 9, 2020/Accepted May 13, 2020).
AB - We present the case of a 66-year-old female diagnosed with gallbladder cancer that was initially discovered with contrast enhanced computed tomography. The primary gall bladder tumor displayed heterogeneous enhancement. The patient underwent cholecystectomy with full-thickness excision of the gallbladder cancer. After 3 rounds of adjuvant chemotherapy with the oral fluoropyrimidine derivative, S-1 (administered for 4 weeks at 120 mg/day and then stopped for 2 weeks), a metastasis measuring 15 mm in diameter emerged within hepatic segment 5. The chemotherapy regimen was altered to include 6 months of combination therapy with gemcitabine (1,000 mg/m') and cisplatin (25 mg/m2) given once every week for 2 weeks and then stopped for 1 week. The hepatic metastasis decreased in size to 8 mm in diameter, and a partial liver resection was performed. After hepatectomy, the patient remains alive and without disease recurrence. Key words: Liver metastasis of gallbladder cancer, Chemotherapy, Metachronous liver metastasis (Received Mar. 9, 2020/Accepted May 13, 2020).
UR - http://www.scopus.com/inward/record.url?scp=85095386532&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85095386532&partnerID=8YFLogxK
M3 - Article
C2 - 33130750
AN - SCOPUS:85095386532
SN - 0385-0684
VL - 47
SP - 1501
EP - 1504
JO - Japanese Journal of Cancer and Chemotherapy
JF - Japanese Journal of Cancer and Chemotherapy
IS - 10
ER -